Analyst Research

Report Title Price
Provider: Sadif Analytics Prime
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Swedish Orphan Biovitrum publ AB issues FY 2014 gross margin guidance and FY 2014 revenue guidance in line with analysts' estimates

Thursday, 20 Feb 2014 02:00am EST 

Swedish Orphan Biovitrum publ AB:Says it expects total revenues for the full year 2014 to be in the range of between 2,300 mln Swedish crowns and 2,500 mln Swedish crowns and the gross margin to be in the range of between 58 pct and 60 pct.FY 2014 revenues 2,353.59 mln Swedish crowns - Thomson Reuters I/B/E/S.